U.S. market Closed. Opens in 1 day 9 hours 31 minutes

ABEO | Abeona Therapeutics Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 5.34 - 5.75
52 Week Range 3.05 - 9.01
Beta 1.48
Implied Volatility 275.01%
IV Rank 6.05%
Day's Volume 192,984
Average Volume 360,387
Shares Outstanding 43,314,400
Market Cap 240,394,920
Sector Healthcare
Industry Biotechnology
IPO Date 1980-09-19
Valuation
Profitability
Growth
Health
P/E Ratio -3.14
Forward P/E Ratio N/A
EPS -1.77
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 84
Country USA
Website ABEO
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.
*Chart delayed
Analyzing fundamentals for ABEO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ABEO Fundamentals page.

Watching at ABEO technicals we can see that long-term trend is bullish, while middle-term trend is bearish, but short-term trend is bullish. More technicals details can be found on ABEO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙